“Patient safety is paramount to the Commission, and we are working with the Department of Health and others to determine whether any medical cannabis patients may be experiencing similar symptoms,” Will Tilburg, the commission’s acting executive director, said in the advisory, which went to about 100,000 registered patients, 1,500 medical providers and 130 businesses.